Genetic factors and pathogenesis of waldenström's macroglobulinemia

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Waldenström's macroglobulinemia (WM) is an indolent but incurable B-cell malignancy. Over the last decade, advances in the molecular field brought about by the use of high-throughput genomic analyses - including array-based comparative genomic hybridization and massively parallel genome sequencing - have considerably improved our understanding of the genetic basis of WM. Its pathogenesis, however, remains fragmented. Important steps have been made in elucidating the underlying aberrations and deregulated mechanisms of the disease, and thereby providing invaluable information for identifying biomarkers for disease diagnosis, risk stratification, and therapeutic approaches. We review the genetic basis of the disease.

Original languageEnglish (US)
Pages (from-to)450-456
Number of pages7
JournalCurrent oncology reports
Issue number5
StatePublished - Oct 2013


  • Array-based comparative genomic hybridization
  • Genetics
  • MYD88
  • Massively parallel DNA sequencing
  • Waldenström's macroglobulinemia

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Genetic factors and pathogenesis of waldenström's macroglobulinemia'. Together they form a unique fingerprint.

Cite this